Tuesday, March 3, 2009

Genzyme Shows Biotech Drugs Are Tough to Reproduce

The company's trouble getting approval to expand production of its Pompe disease drug highlights a problem that could await would-be makers of generic biologics.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)